Morphine 2 mg/mL CADD Cassettes Recalled for Sterility Concerns
Medical Center Pharmacy is recalling Morphine 2 mg/mL CADD Cassettes because production processes cannot assure sterility. Patients in Tennessee who received specific prescriptions should contact their healthcare provider.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the hazard involves a lack of assurance of sterility in a parenteral medication, which poses a significant risk of serious injury or infection.
Plain-English summary
Medical Center Pharmacy, Inc. is recalling Morphine 2 mg/mL Cassettes (100 mL CADD Cassette, Rx only, NDC 00409-1134-03). The recall is due to concerns with production processes that cannot assure the sterility of products intended to be sterile.
The affected product is identified by Lot 03032020@34 with a Beyond-Use Date of 03/17/2020. Distribution was limited to specific prescriptions for patients in Tennessee.
Patients who have received this product should contact their healthcare provider for instructions on what to do next.
The recalled product
- Product
- *Morphine 2 mg/mL Cassette, 100 mL CADD Cassette, Rx only, Medical Center Pharmacy, 2401 N. Ocoee Street, Cleveland, TN 37311, NDC 00409-1134-03.
- Manufacturer
- Medical Center Pharmacy, Inc.
- Category
- Drug — Sterile Injectable
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 03032020@34 BUD: 03/17/2020
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 5 recalled by Medical Center Pharmacy, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Medical Center Pharmacy, Inc.
See all →- SevereMedical Center Pharmacy Recalls Mitomycin Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2020-04-08
- SevereMedical Center Pharmacy Recalls C-Albumin Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2020-04-08
- SevereMedical Center Pharmacy Recalls Vancomycin Opthal Drops Due to Sterility Concerns
FDA (Drugs) · 2020-04-08
- SevereMedical Center Pharmacy Recalls Gentamicin Bladder Irrigation Bags
FDA (Drugs) · 2020-04-08
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SeverePharmakon Recalls Morphine Sulfate Cadd Cassettes Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SeverePharmakon Recalls Hydromorphone Cadd Cassettes Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SevereGuardian Pharmacy Recalls Morphine Sulfate CADD Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SeverePharmakon Recalls Fentanyl Citrate Cadd Cassettes Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SeverePharmakon Recalls Morphine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SeverePharMEDium Recalls Ropivacaine Cassettes Due to Sterility Concerns
FDA (Drugs) · 2015-09-16